Efficacy News and Research

RSS

Meta-analysis showcases the long-term benefits of COVID-19 vaccines against hospitalization & death

A meta-analysis on the long-term vaccine effectiveness of four COVID-19 vaccines.

14 Feb 2023

Cabometyx® in combination with nivolumab shows durable survival benefits at over three-years’ follow-up in first-line advanced renal cell carcinoma

Ipsen (Euronext: IPN; ADR: IPSEY) today announced three-year minimum, 44-month median, follow-up results from the Phase III CheckMate -9ER trial showing that Cabometyx® (cabozantinib) in combination with nivolumab provides survival and response rate benefits after three-years in the first-line treatment of advanced renal cell carcinoma (aRCC), compared to sunitinib.

From Ipsen 14 Feb 2023

Do nuts help with type 2 diabetes?

Type 2 diabetes is a metabolic disorder that affects one in ten people worldwide. There has been an alarming increase of 16% in the global prevalence of type 2 diabetes over the past two years.

13 Feb 2023

Changes in SARS-CoV-2 antibody titers after COVID-19 vaccination

Researchers assess longitudinal alterations in SARS-CoV-2 IgG antibody titers after vaccination.

13 Feb 2023

Exploring two small molecules for the disintegration of alpha-synuclein fibrils

In a recent study published in the Proceedings of the National Academy of Sciences, researchers assessed the capability of two small molecules of disintegrating alpha-synuclein fibrils.

13 Feb 2023

Two cardiovascular drugs may help improve outcomes for patients who experienced small vessel stroke

A study of two widely used cardiovascular medications — cilostazol and isosorbide mononitrate — in more than 350 patients confirmed the two medications were well-tolerated and safe for people who have experienced a stroke in a small blood vessel deep in the brain.

13 Feb 2023

Researchers report a physical barrier against SARS-CoV-2 infection based on an inhalable bioadhesive hydrogel

Researchers developed spherical hydrogel inhalation for enhanced lung defense to protect against SARS-CoV-2 infections.

13 Feb 2023

The immunogenicity of two leading malaria vaccine candidates delivered as mRNA-LNP vaccines

Researchers evaluated the immunogenicity of two vaccine candidates, Pfs25 and PfCSP, based on the mRNA-lipid nanoparticle (LNP) platform.

13 Feb 2023

Vaccine efficacy and booster dose combinations among 18.9 million adults in the early phase of Omicron

A new study in the journal Clinical Infectious Diseases aimed to determine the relative vaccine effectiveness (rVE) in three different recipient cohorts, those who received the Ad26.COV2.S vaccine followed by Ad26.COV2.S booster, those who received the Ad26.COV2.S vaccine followed by an mRNA booster, and those who received two doses of an mRNA vaccine followed by an mRNA booster.

12 Feb 2023

UQ-led research effort secures almost $8 million to develop an mRNA Strep A vaccine

A University of Queensland-led research effort to develop an mRNA vaccine against Group A Streptococcus (Strep A) has secured almost $8 million in philanthropic funding.

10 Feb 2023

Pegylated interferon lambda shows good efficacy against COVID-19

In a recent study published in The New England Journal of Medicine, researchers used the TOGETHER platform trial protocol to perform a phase III randomized controlled trial (RCT) to evaluate the effectiveness of pegylated interferon (IFN) lambda (λ) therapy in outpatients with coronavirus disease 2019 (COVID-19) in Canada and Brazil.

9 Feb 2023

Novel COVID-19 protein component vaccine elicits durable immune response in rodents

Researchers describe a novel SARS-CoV-2 spike protein component vaccine called MT-001.

9 Feb 2023

New formulation can provide up to six months of full protection against HIV

For people at high risk of contracting HIV, missing doses of their daily HIV prevention pills can have big consequences. In some cases, missing a pill can lead to lack of protection against the virus.

9 Feb 2023

New milestones for the treatment of hemophilia

Hemophilia A is the most common severe form of hemophilia. It affects almost exclusively the male sex. The disease can usually be treated well, but the medicines known so far do not help all of those affected.

9 Feb 2023

Researchers find a way to block anaphylaxis caused by peanut allergies

Researchers from Indiana University School of Medicine have found a way to block anaphylaxis caused by peanut allergies.

9 Feb 2023

Can commercial AI-based CAD software improve the detection rate of actionable lung nodules on chest radiographs?

Researchers performed a single-center, open-label RCT to investigate whether commercial AI-debased CAD system could improve the detection rate of actionable lung nodules on chest radiographs.

9 Feb 2023

COVID-19 vaccination increases saliva antibody levels after asymptomatic infection

Researchers correlate SARS-CoV-2 load and neutralizing capacity of all saliva immunoglobulins isotypes in asymptomatic individuals.

8 Feb 2023

Investigating the association between lipid profile and coronary heart disease by race

In a recent study published in the Journal of the American College of Cardiology, researchers investigated the use of serological high-density lipoprotein cholesterol (HDL-C) values to estimate the risk of coronary heart disease (CHD) among adult Black and White individuals.

8 Feb 2023

Pandemic-related challenges faced by pregnant women, new mothers, and their families in maternal and newborn care

Researchers discussed the challenges faced by pregnant individuals amid the COVID-19 pandemic.

8 Feb 2023

Cellular and humoral responses and the safety of recombinant and inactivated SARS-CoV-2 vaccines in chronic kidney disease patients

Researchers investigated the B cell and humoral immune responses elicited against inactivated and recombinant SARS-CoV-2 vaccines and their safety profiles in patients with CKD.

8 Feb 2023

Efficacy News and Research

Meta-analysis showcases the long-term benefits of COVID-19 vaccines against hospitalization & death

Cabometyx® in combination with nivolumab shows durable survival benefits at over three-years’ follow-up in first-line advanced renal cell carcinoma

Do nuts help with type 2 diabetes?

Changes in SARS-CoV-2 antibody titers after COVID-19 vaccination

Exploring two small molecules for the disintegration of alpha-synuclein fibrils

Two cardiovascular drugs may help improve outcomes for patients who experienced small vessel stroke

Researchers report a physical barrier against SARS-CoV-2 infection based on an inhalable bioadhesive hydrogel

The immunogenicity of two leading malaria vaccine candidates delivered as mRNA-LNP vaccines

Vaccine efficacy and booster dose combinations among 18.9 million adults in the early phase of Omicron

UQ-led research effort secures almost $8 million to develop an mRNA Strep A vaccine

Pegylated interferon lambda shows good efficacy against COVID-19

Novel COVID-19 protein component vaccine elicits durable immune response in rodents

New formulation can provide up to six months of full protection against HIV

New milestones for the treatment of hemophilia

Researchers find a way to block anaphylaxis caused by peanut allergies

Can commercial AI-based CAD software improve the detection rate of actionable lung nodules on chest radiographs?

COVID-19 vaccination increases saliva antibody levels after asymptomatic infection

Investigating the association between lipid profile and coronary heart disease by race

Pandemic-related challenges faced by pregnant women, new mothers, and their families in maternal and newborn care

Cellular and humoral responses and the safety of recombinant and inactivated SARS-CoV-2 vaccines in chronic kidney disease patients

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News